Do you offer OEM or ODM services?

Yes, we provide both OEM and ODM services for our customers.

What certifications does the product have?

The product is manufactured with GMP and ISO certifications.

What are the payment terms accepted?

We accept LC, T/T, D/P, PayPal, Western Union, and small-amount payments.

Manufacture Feed Material Perilla Leaf Powder for Animal Use with GMP ISO

Name: Manufacture Feed Material Perilla Leaf Powder for Animal Use with GMP ISO
Brand: Henan Muxiang Biological Co., Ltd.
SKU: 1978484342

Henan, ChinaHenan Muxiang Biological Co., Ltd.

US$1.99-2.99

600 Bags

Sample price:US$5.00/bag.Request sample

Product profile

Customization

Available

Certification

ISO, ISO

Shape

Powder

Model NO.

powder

Type

Functional Additives

Function

Bacteriostasis Growth Promoter

Transport Package

25kg/Carton

Specification

100g/bag

Trademark

MOOSUN

Origin

China

HS Code

2309901000

Production Capacity

500t/Month

Key features

Natural Active Ingredients: Contains rosmarinic acid, flavonoids, polyphenols, and volatile oils.

Antiviral and Antibacterial Effects: Effective against avian influenza H9N2 and various viral infections.

GMP and ISO Certified: Manufactured under strict GMP and ISO quality standards.

No Drug Residue: Natural, green, and safe treatment with no harmful residues.

OEM and ODM Services: Customization options available for manufacturing and branding.

Long Shelf Life: Product remains effective for up to 2 years when stored properly.

Veterinary Application: Specifically designed for veterinary use in animal feed.

Global Market Reach: Exports to North America, Europe, Asia, and other international regions.

Company profile

Henan Muxiang Biological Co., Ltd.

Henan, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service Available & OEM Service AvailableExport Year: 2016-02-01 CertifiedNearest Port: Shanghai Port, Qingdao PortAverage Response Time: ≤10.58h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryHenan Muxiang Biological Co., Ltd. is a China-based limited-company factory established in 2004, with 360 employees and operations in veterinary pharmaceuticals and animal-health products. The supplier reports seven pharmaceutical production lines, eight vaccine production lines, first-class production and inspection equipment, GMP management, ISO9001:2015 certification, and ISO/CNAS laboratory certification. Its R&D resources include more than 40 core personnel, over 30 of whom hold doctoral or master's degrees, while 21–30 quality-control staff are reported. The company exports to multiple global regions, has self-operated import and export rights, and states a one-month order-fulfillment period in both peak and off-peak seasons. Evidence supports capabilities in certification, innovation, production, and international operations. However, the provided information does not sufficiently establish after-sales service performance, financial credibility, customization execution, or specific customer cases.

Supplier typeThe supplier is identified as a limited company and a factory in the manufacturing industry, with its operating location in Henan, China. This indicates a direct manufacturing entity rather than only a trading or intermediary business.

CertificationsThe supplier reports a systematic GMP management system, ISO/CNAS laboratory international certification, and an ISO9001:2015 certificate. These stated certifications and quality systems provide explicit evidence of formal quality-management capability.

R&D capabilityThe supplier reports more than 40 core R&D personnel, including over 30 doctors or master's degree graduates, 20 years of preparation-technology experience among R&D engineers, and advanced R&D platforms such as a National Enterprise Technology Center, National Postdoctoral Research Station, and Academician Workstation. It also reports improving herbal active-ingredient extraction by more than 30% versus a traditional process, supporting a strong stated innovation profile.

Production capacityThe supplier reports seven pharmaceutical production lines and eight vaccine production lines, first-class production and inspection equipment, six production lines in a separate operational data field, and one-month order fulfillment in both peak and off-peak seasons. Although the line-count figures are not fully consistent across the slices, the evidence clearly supports substantial pharmaceutical and vaccine manufacturing capability.